Market revenue in 2023 | USD 124.7 million |
Market revenue in 2030 | USD 266.2 million |
Growth rate | 11.4% (CAGR from 2023 to 2030) |
Largest segment | Reagents & media |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Media, Equipment, Accessories and consumables, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Danaher Corp, Sartorius AG, Merck KGaA, Corning Inc, Lonza Group Ltd, Creative-Biolabs, Wuxi AppTec Co Ltd, Advanced Instruments |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell line development market will help companies and investors design strategic landscapes.
Reagents & media was the largest segment with a revenue share of 43.3% in 2023. Horizon Databook has segmented the Australia cell line development market based on reagents & media, equipment, accessories and consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia cell line development market , including forecasts for subscribers. This country databook contains high-level insights into Australia cell line development market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account